Cargando…
The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947737/ https://www.ncbi.nlm.nih.gov/pubmed/31942097 http://dx.doi.org/10.4103/JOC.JOC_164_18 |
_version_ | 1783485617433214976 |
---|---|
author | Strandby, Rune B. Svendsen, Lars B. Ambrus, Rikard Rostved, Andreas A. Hasselby, Jane P. Achiam, Michael P. |
author_facet | Strandby, Rune B. Svendsen, Lars B. Ambrus, Rikard Rostved, Andreas A. Hasselby, Jane P. Achiam, Michael P. |
author_sort | Strandby, Rune B. |
collection | PubMed |
description | CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conventional cytopathological methods and immunohistochemical staining for the analysis of peritoneal washings. SETTINGS AND DESIGN: A prospective study conducted at a single tertiary referral hospital. MATERIALS AND METHODS: Patients with gastroesophageal junction cancer and without suspicion of intra- or extraabdominal metastases before the staging laparoscopy were prospectively and consecutively enrolled. Peritoneal washing cytology was performed at staging laparoscopy (primary cytology) and after neoadjuvant chemotherapy during robot-assisted or open resection (secondary cytology). Peritoneal fluid samples were analyzed by conventional cytology and an immunohistochemical panel. RESULTS: Overall, 81 patients met the primary inclusion criteria. During primary cytology, positive cytology without overt metastases (C1M0) was detected in three patients (3.8%) while five patients (6.3%) had overt intra-abdominal metastases but negative cytology (C0M1). None of the patients with C1M0 underwent surgery due to extra-abdominal (n = 1) or intra-abdominal metastases (n = 2), and the overall survival was 4, 7, and 14 months. During secondary cytology, no patients with free peritoneal tumor cells were identified, but seven patients were classified as C0M1 (10.9%). CONCLUSIONS: The incidence of C1M0 was 3.8% and 0% before and after neoadjuvant chemotherapy, respectively in patients with gastroesophageal junction cancer. Free peritoneal tumor cells were not identified in several patients with intra-abdominal metastases suggesting that peritoneal washing cytology with conventional cytology and immunohistochemical staining lack sensitivity. |
format | Online Article Text |
id | pubmed-6947737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69477372020-01-15 The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer Strandby, Rune B. Svendsen, Lars B. Ambrus, Rikard Rostved, Andreas A. Hasselby, Jane P. Achiam, Michael P. J Cytol Original Article CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conventional cytopathological methods and immunohistochemical staining for the analysis of peritoneal washings. SETTINGS AND DESIGN: A prospective study conducted at a single tertiary referral hospital. MATERIALS AND METHODS: Patients with gastroesophageal junction cancer and without suspicion of intra- or extraabdominal metastases before the staging laparoscopy were prospectively and consecutively enrolled. Peritoneal washing cytology was performed at staging laparoscopy (primary cytology) and after neoadjuvant chemotherapy during robot-assisted or open resection (secondary cytology). Peritoneal fluid samples were analyzed by conventional cytology and an immunohistochemical panel. RESULTS: Overall, 81 patients met the primary inclusion criteria. During primary cytology, positive cytology without overt metastases (C1M0) was detected in three patients (3.8%) while five patients (6.3%) had overt intra-abdominal metastases but negative cytology (C0M1). None of the patients with C1M0 underwent surgery due to extra-abdominal (n = 1) or intra-abdominal metastases (n = 2), and the overall survival was 4, 7, and 14 months. During secondary cytology, no patients with free peritoneal tumor cells were identified, but seven patients were classified as C0M1 (10.9%). CONCLUSIONS: The incidence of C1M0 was 3.8% and 0% before and after neoadjuvant chemotherapy, respectively in patients with gastroesophageal junction cancer. Free peritoneal tumor cells were not identified in several patients with intra-abdominal metastases suggesting that peritoneal washing cytology with conventional cytology and immunohistochemical staining lack sensitivity. Wolters Kluwer - Medknow 2020 2019-12-23 /pmc/articles/PMC6947737/ /pubmed/31942097 http://dx.doi.org/10.4103/JOC.JOC_164_18 Text en Copyright: © 2019 Journal of Cytology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Strandby, Rune B. Svendsen, Lars B. Ambrus, Rikard Rostved, Andreas A. Hasselby, Jane P. Achiam, Michael P. The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title_full | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title_fullStr | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title_full_unstemmed | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title_short | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
title_sort | incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947737/ https://www.ncbi.nlm.nih.gov/pubmed/31942097 http://dx.doi.org/10.4103/JOC.JOC_164_18 |
work_keys_str_mv | AT strandbyruneb theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT svendsenlarsb theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT ambrusrikard theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT rostvedandreasa theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT hasselbyjanep theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT achiammichaelp theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT strandbyruneb incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT svendsenlarsb incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT ambrusrikard incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT rostvedandreasa incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT hasselbyjanep incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer AT achiammichaelp incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer |